COVID-19 and IBD Drugs
We are recommending that all IBD patients using immune drugs REMAIN on their immune drugs, including Azathioprine, Imuran, 6-MP, Infliximab, Humira, Entyvio, Stelara, and Xeljanz.
IBD and COVID-19 Vaccine
There has been confusion whether persons with IBD are safe to get the vaccine. Patients with IBD who are eligible for the vaccine should receive it. There should not be any safety issues for IBD patients different than the general public with the types of vaccine that are currently in use.
What is the IBD Clinical and Research Centre?
In 1994, Dr. Charles N. Bernstein established the Inflammatory Bowel Disease (IBD) Clinical and Research Centre, a Manitoba-based network of clinicians, researchers, and trainees working collaboratively to improve health outcomes for persons living with Crohn's disease and ulcerative colitis. The centre, which has received international attention and recognition for its research, has established among the largest IBD population databases in North America.
the clinicians, scientists, analysts, administration, and trainees that comprise our team ...
about different topics associated with IBD ...
how to get involved in current patient participation studies and clinical treatment trials ...
how to get in touch with our study teams ...
News & Events
for research participants, healthcare professionals, and clinical collaborators ...
Study of first degree relatives of patients with Crohn’s disease
We want to learn if any siblings or children of persons with Crohn’s disease are at risk for getting Crohn’s disease.
For more information please contact: Diane McAlpine at 204-787-1643
Are you having a colonoscopy?
The Imid Study:
Understanding the effects of stress, anxiety, depression & chronic disease
Seeking Patient Advisers with IBD to join our
PATIENT ADVISORY COMMITTEE
John R Walker, PhD. John joined our group in 2002, as a collaborator on our CIHR-funded research study entitled “Understanding the biological, clinical, and psychosocial determinants of health outcomes in inflammatory bowel disease: A research program.” At that time John was already a well known, highly regarded and beloved clinical psychologist in Winnipeg. He established the Anxiety Disorders Clinic at St. Boniface Hospital and co-founded the Anxiety Disorders Association of Manitoba. John also had extensive expertise in knowledge translation. It was his passion to understand patient information needs and optimal ways to deliver patient information. He was an invaluable member of our GI research group. While he started with the IBD research team, he branched out and became an integral member of research groups led by Harminder Singh exploring ways to optimize colonoscopy and Don Duerksen examining a longitudinal celiac disease cohort study. More recently, his expertise was invaluable in our CIHR funded collaborative study with colleagues in neurology and rheumatology exploring psychiatric comorbidity in chronic immune diseases. John’s intellect, skills, creativeness and kindness will be sorely missed.
Denis Krause, PhD. Denis joined our group in 2003, having taken a position as Associate Professor of Agriculture in the Department of Animal Sciences at the University of Manitoba. He had left a position in Queensland Australia and moved his young family to to Winnipeg. He was an expert veterinary microbiologist with a special interest in IBD. He was awarded with millions of dollars in research grants and was regarded as one of the young starts of the University of Manitoba. He was a very important friend and collaborator of our IBD team. His untimely death at age 46 from cancer leaves behind rich memories of his loving family of wife Alice and sons David, Jonathon and Josh.